Stock Analysis of RenovoRx Inc (RNXT) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code RNXT
Close 1.16
Change -0.0100 / 0.855 %
Volume 13225.00
Vol Change -10926.00 / 45.24 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Good Stability


Fundamental View of RenovoRx Inc
PE (TTM)

-1.21

Very Poor
Price / Book

-39.71

Very Poor
Price / Sales

0

Very Poor
Piotroski F Score

0.0

Very Poor
Market Cap

27784.09 K

Enterprise Value

26611.09 K

ROA (TTM)

-294.41

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

6.24 %

-9161.00 K
Debt to Equity

0

Excellent
Altman Z Score

-56.19

Very Poor
Quick Ratio

0

Poor
Cash Ratio

0.998

Not Good


Highs/Lows of RenovoRx Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week1.26 7.94 % 0.513 % 1.311.1528-May-2431-May-24
Two Week1.37 15.33 % 0.486 % 1.431.1520-May-2431-May-24
One Month1.21 4.13 % 4.80 % 1.481.1415-May-2401-May-24
Three Month1.72 32.56 % 3.56 % 1.861.108-Mar-2417-Apr-24
Six Months0.64 81.25 % 15.54 % 2.350.548829-Dec-2306-Dec-23
One year1.86 37.63 % 26.26 % 3.290.548829-Jun-2306-Dec-23
Two year1.96 40.82 % 27.72 % 5.7450.548807-Mar-2306-Dec-23


Technical View of RenovoRx Inc
RSI

38.54

Neutral
MACD

-0.0205

Bullish
ADX

23.48

Neutral
Super Trend

1.51

Mild Bearish
Williams %R

-96.97

Mild Bearish
CCI

-130.19

Bearish


EMA 5

1.22

Strong Bearish
EMA 15

1.29

Strong Bearish
EMA 50

1.31

Bearish
EMA 100

1.32

Mild Bearish
SMA 100

1.35

Whipsaw
SMA 200

1.27

Mild Bearish
SMA 5 / 20

1.22 / 1.33

Bearish
SMA 15 / 50

1.34 / 1.28

Mild Bullish
SMA 50 / 200

1.28 / 1.27

Strong Bearish




Charts of RenovoRx Inc


Returns of RenovoRx Inc with Peers
Period / StockRNXTAXDXICUBIVI
1 Week-7.94%-13.77%-0.509%0.286%
1 Mth-4.13%34.98%-22.66%-7.04%
3 Mth-32.56%20.80%-49.37%-63.27%
6mth81.25%-72.45%-27.02%-74.69%
1 Year-37.63%-83.02%-28.58%-92.20%
2 Year-40.82%-80.49%--82.21%
5 Years--99.37%--96.36%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of RenovoRx Inc with Peers
Ratio / StockRNXTAXDXICUBIVI
PE-1.21-0.256-0.400-0.489
P/B-39.71-0.445-0.9071.25
ROA-294.41-136.03-1123.52-115.35
ROE000-255.49
Debt To Equity0-1.93-0.5500.0033
Revenue0
% 		12004.00 K
5.87 % 		0
% 		0
%
Net Income-9161.00 K
6.24 % 		-63229.00 K
1.18 % 		-35572.00 K
54.57 % 		-50255.82 M
192565 %


Technicals of RenovoRx Inc with Peers
Technical / StockRNXTAXDXICUBIVI-
ADX23.4830.4311.7912.91
CMF-0.2540.221-0.2000.087
MFI18.5986.5354.2130.71
RSI38.5456.5139.0539.71
MACD Abv SignalFalseTrueTrueTrue
Price Above 50 MAFalseTrueFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : RenovoRx Inc

Address : 4546 El Camino Real, Los Altos, CA, United States, 94022
Tel : 650 284 4433
URL : https://renovorx.com
Code : RNXT, ISIN : US75989R1077, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 26_Aug_2021
Employee Count : 10

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)